Invasive Fungal Disease Clinical Trial
Official title:
A Clinical Study on the Efficacy and Safety of Amphotericin B Cholesteryl Sulfate Complex for Injection in the Empirical First-line Treatment of Patients With Invasive Fungal Diseases
This study is a prospective, multicenter, single-arm study, that aims to evaluate the efficacy and safety of amphotericin B cholesterol-sulfate complex (ABCD) for injection in the first-line treatment of patients with invasive fungal diseases, hoping to provide a reference for the clinical treatment of invasive fungal diseases. Patients with hematologic diseases who meet the criteria for inclusion and discharge with febrile neutropenia and suspected fungal infection were treated with ABCD antifungal therapy for 14 days while receiving treatment for underlying diseases, and the response rate of treatment was observed.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05116059 -
To Evaluate the Efficacy and Safety of ABCD in the Treatment of IFD
|
||
| Completed |
NCT01916057 -
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
|
N/A | |
| Completed |
NCT03262584 -
Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
|
||
| Recruiting |
NCT04368559 -
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
|
Phase 3 | |
| Not yet recruiting |
NCT06285188 -
Immunomonitoring of Mold Invasive Infections
|
||
| Recruiting |
NCT01731353 -
FungiScope - A Global Emerging Fungal Infection Registry
|
||
| Recruiting |
NCT05569824 -
LFD of Aspergillus Antigen in Paediatrics
|
||
| Completed |
NCT03577509 -
Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China
|
Phase 1 | |
| Recruiting |
NCT03774316 -
De-escalation - Antifungal Treatment Immunocompromised Patients
|
||
| Recruiting |
NCT05630976 -
Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi
|
Phase 4 | |
| Completed |
NCT01259713 -
Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia
|
Phase 3 | |
| Recruiting |
NCT01135589 -
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
|
Phase 4 |